EyePoint Pharmaceuticals gets grant for treatment of ocular conditions with multi-specific compounds
Discover the groundbreaking patent by EyePoint Pharmaceuticals Inc for treating ocular conditions with multi-specific compounds targeting phosphatase and receptor tyrosine kinase agonists. Revolutionize eye care with Tie2 activation and VEGF inhibition.
Discover the groundbreaking patent by EyePoint Pharmaceuticals Inc for treating ocular conditions with multi-specific compounds targeting phosphatase and receptor tyrosine kinase agonists. Revolutionize eye care with Tie2 activation and VEGF inhibition.
What's Your Reaction?
